Comparison of urethral diameters for calculating the urethral dose after permanent prostate brachytherapy

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 25, Issue 7, 2007, Pages 329-334

  Tanaka, Osamu ^a,b   Hayashi, Shinya ^a,b   Matsuo, Masayuki ^a,b   Nakano, Masahiro ^a   Kubota, Yasuaki ^a   Maeda, Sunaho ^a,b   Ohtakara, Kazuhiro ^a,b   Deguchi, Takashi ^a   Hoshi, Hiroaki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

CT MRI fusion; Postplan; Prostate brachytherapy; Urethral dose

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; MALE; NIDATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; RADIATION DOSE; URETHRA VALVE; COMPARATIVE STUDY; ENDOSCOPIC ECHOGRAPHY; HISTOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; RADIATION EXPOSURE; URETHRA;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

BRACHYTHERAPY; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL; URETHRA;

EID: 38449122439     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0146-2     Document Type: Article

References (20)

1. K Wallner J Roy L Harrison 1995 Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 32 465 71
2. GS Merrick WM Butler KE Wallner RW Galbreath B Murray D Zeroski 2003 Dysuria after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 53 979 85
3. MJ Zelefsky Y Yamada C Marion S Sim G Cohen L Ben-Porat 2003 Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy Int J Radiat Oncol Biol Phys 55 956 63
4. DY Gelblum L Potters R Ashley R Waldbaum XH Wang S Leibel 1999 Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 59 67
5. J Desai RG Stock NN Stone C Iannuzzi JK DeWyngaert 1998 Acute urinary morbidity following I-125 interstitial implantation of the prostate gland Radiat Oncol Invest 6 135 41
6. GS Merrick WM Butler BG Tollenaar RW Balbeath JH Lief 2002 The dosimetry of prostate brachytherapy-induced urethral strictures Int J Radiat Oncol Biol Phys 52 461 8
7. D Brown A Colonias R Miller R Benoit J Cohen Y Arshoun 2000 Urinary morbidity with a modified peripheral loading technique of transperineal (125)I prostate implantation Int J Radiat Oncol Biol Phys 47 353 60
8. FM Waterman AP Dicker 2000 Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan Med Phys 27 448 51
9. WM Butler GS Merrick AT Dorsey BM Hagedorn 2000 Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy Int J Radiat Oncol Biol Phys 48 1575 82
10. MA Elshaikh K Angermeier JC Ulchaker EA Klein MA Chidel S Mahoney 2003 Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy Urology 61 152 5
11. S Nag W Bice K DeWyngaert B Prestidge R Stock Y Yu 2000 The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int J Radiat Oncol Biol Phys 46 221 30
12. S Nag RJ Ellis GS Merrick R Bahnson K Wallner R Stock 2002 American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy Int J Radiat Oncol Biol Phys 54 462 70
13. GS Merrick WM Butler KE Wallner RW Galbreath RL Anderson ZA Allen 2006 Risk factors for the development of prostate brachytherapy related urethral strictures J Urol 175 1376 80
14. FM Waterman AP Dicker 2000 The impact of postimplant edema on the urethral dose in prostate brachytherapy Int J Radiat Oncol Biol Phys 47 661 4
15. HK Lee WD D'Souza JM Yamal A Pollack AK Lee MB Palmer 2003 Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 57 355 61
16. JM Crook L Potters RG Stock MJ Zelefsky 2005 Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk Brachytherapy 4 186 94
17. ZA Allen GS Merrick WM Butler KE Wallner B Kurko RL Anderson 2005 Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity Int J Radiat Oncol Biol Phys 62 981 7
18. O Tanaka S Hayashi K Sakurai M Matsuo M Nakano S Maeda 2006 Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry prostate brachytherapy Radiother Oncol 81 303 8
19. O Tanaka S Hayashi M Matsuo K Sakurai M Nakano S Maeda 2006 Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy Int J Radiat Oncol Biol Phys 66 597 602
20. W Warwick D Bannister 1989 Gray's Anatomy 37th edition Churchill Livingstone Edinburgh 1421